Reports for BUPRENORPHINE

Ingredient

BUPRENORPHINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PMS-BUPRENORPHINE-NALOXONE 0.5MG 2MG TABLET Resolved 2024-07-24 2024-10-09 233605
PMS-BUPRENORPHINE-NALOXONE 2MG 0.5MG TABLET Resolved 2017-03-14 2017-11-23 2352
PMS-BUPRENORPHINE-NALOXONE 2MG 0.5MG TABLET Avoided shortage 2019-03-29 2019-05-01 79878
PMS-BUPRENORPHINE-NALOXONE 2MG 0.5MG TABLET Resolved 2019-06-11 2019-07-03 86234
SUBLOCADE 300MG SOLUTION (EXTENDED RELEASE) Resolved 2022-02-24 2022-03-03 155534
SUBLOCADE 100MG SOLUTION (EXTENDED RELEASE) Resolved 2020-09-01 2021-03-10 123461
SUBLOCADE 300MG SOLUTION (EXTENDED RELEASE) Resolved 2020-09-01 2021-01-27 123466
SUBOXONE 0.5MG 2MG TABLET Resolved 2025-03-18 2025-04-01 252977
SUBOXONE 8MG 2MG TABLET Resolved 2018-10-30 2018-11-13 65865
SUBOXONE 2MG 8MG FILM, SOLUBLE Resolved 2023-04-13 2023-05-19 189554

Showing 21 to 30 of 39

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BELBUCA 75MCG FILM, SOLUBLE Discontinued 2019-03-28 2019-04-02 79766
BELBUCA 150MCG FILM, SOLUBLE Discontinued 2019-04-01 2019-04-02 80230
BELBUCA 300MCG FILM, SOLUBLE Discontinued 2019-04-01 2019-04-02 80233
BELBUCA 450MCG FILM, SOLUBLE Discontinued 2019-04-01 2019-04-02 80236
MYLAN-BUPRENORPHINE/NALOXONE Discontinued 2019-09-17 2019-09-18 94044
MYLAN-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Discontinued 2019-09-17 2019-09-18 94048

Showing 1 to 6 of 6